Early Heparin therapy improves hypoxia in COVID-19 patients

Early Heparin therapy improves hypoxia in COVID-19 patients

Early Heparin therapy improves hypoxia in COVID-19 patients

The systemic use of heparin for treating severe coronavirus disease (COVID-19) showed significant improvements in oxygen exchange and overall clinical presentation of patients, as reported by a study from Brazil available on a preprint server medRxiv.